Bal, S., Htut, M., Berdeja, J., Anderson, L., Rossi, A., Gregory, T., Costa, L., Hu, H., Guo, Z., Chen, J., Jordahl, K., Sarkis, N., Ziyad, S., Kao, W., Kaeding, A., Burgess, M. and Nadeem, O. (2026) “P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14112.